UnitedHealth Group Receives Average Recommendation of “Buy” from Brokerages (NYSE:UNH)
Shares of UnitedHealth Group (NYSE:UNH) have been given an average rating of “Buy” by the twenty-two brokerages that are presently covering the stock, ARN reports. Two analysts have rated the stock with a sell recommendation, six have given a hold recommendation, nine have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $88.24.
Shares of UnitedHealth Group (NYSE:UNH) traded down 0.01% during mid-day trading on Wednesday, hitting $85.11. The stock had a trading volume of 194,174 shares. UnitedHealth Group has a 52 week low of $66.72 and a 52 week high of $87.24. The stock’s 50-day moving average is $83.04 and its 200-day moving average is $79.42. The company has a market cap of $82.695 billion and a price-to-earnings ratio of 15.57.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, July 17th. The company reported $1.42 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.26 by $0.16. The company had revenue of $32.60 billion for the quarter, compared to the consensus estimate of $32.01 billion. During the same quarter last year, the company posted $1.40 earnings per share. UnitedHealth Group’s revenue was up 7.1% compared to the same quarter last year. On average, analysts predict that UnitedHealth Group will post $5.58 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Tuesday, September 23rd. Investors of record on Friday, September 12th will be paid a dividend of $0.375 per share. This represents a $1.50 annualized dividend and a dividend yield of 1.76%. The ex-dividend date is Wednesday, September 10th.
Several analysts have recently commented on the stock. Analysts at Goldman Sachs downgraded shares of UnitedHealth Group from a “conviction-buy” rating to a “buy” rating in a research note on Thursday, August 7th. Separately, analysts at Sterne Agee reiterated an “underperform” rating on shares of UnitedHealth Group in a research note on Monday, July 21st. They now have a $87.00 price target on the stock, up previously from $80.00. Finally, analysts at Raymond James reiterated a “strong-buy” rating on shares of UnitedHealth Group in a research note on Friday, July 18th. They now have a $98.00 price target on the stock, up previously from $87.00.
UnitedHealth Group Incorporated (NYSE:UNH) diversified health and well-being company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.